Related Experiment Video
Updated: Mar 20, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Bilirubin-Induced Neurotoxicity in the Preterm Neonate
1Division of Newborn Medicine, Department of Pediatrics, Magee-Womens Hospital, Children's Hospital of Pittsburgh, Magee-Womens Research Institute, University of Pittsburgh School of Medicine, 300 Halket Street, Pittsburgh, PA 15213, USA.
Insights
Bilirubin neurotoxicity poses risks to preterm infants due to immature brains. Even low bilirubin levels can cause kernicterus, especially with low albumin, highlighting the need for vigilance in neonatal care.
Area of Science:
- Neonatal Medicine
- Neuroscience
- Toxicology
Background:
- Bilirubin-induced neurotoxicity is a significant concern in preterm neonates.
- Multiple pathways, including oxidative stress and neuroinflammation, contribute to neuronal injury.
- Preterm infants' immature central nervous systems increase vulnerability.
Purpose of the Study:
- To review the mechanisms of bilirubin neurotoxicity in preterm neonates.
- To highlight the clinical manifestations and risk factors for bilirubin-induced brain injury.
- To emphasize the continued occurrence of kernicterus even at lower bilirubin levels.
Main Methods:
- Literature review of cellular and molecular mechanisms.
- Analysis of clinical presentations of acute bilirubin encephalopathy.
- Examination of factors contributing to kernicterus in preterm infants.
Main Results:
- Bilirubin toxicity involves plasma membrane damage, excitotoxicity, neuroinflammation, oxidative stress, and cell cycle arrest.
- Acute bilirubin encephalopathy can present subtly as recurrent apnea.
- Low-bilirubin kernicterus is reported in preterm neonates, often linked to hypoalbuminemia.
Conclusions:
- Preterm neonates are uniquely susceptible to bilirubin neurotoxicity.
- Understanding the multifactorial nature of bilirubin injury is crucial for prevention and management.
- Hypoalbuminemia is a key factor in low-bilirubin kernicterus, necessitating careful monitoring.
Abstract:
Bilirubin-induced neurotoxicity in preterm neonates remains a clinical concern. Multiple cellular and molecular cascades likely underlie bilirubin-induced neuronal injury, including plasma membrane perturbations, excitotoxicity, neuroinflammation, oxidative stress, and cell cycle arrest. Preterm newborns are particularly vulnerable secondary to central nervous system immaturity and concurrent adverse clinical conditions that may potentiate bilirubin toxicity. Acute bilirubin encephalopathy in preterm neonates may be subtle and manifest primarily as recurrent symptomatic apneic events. Low-bilirubin kernicterus continues to be reported in preterm neonates, and although multifactorial in nature, is often associated with marked hypoalbuminemia.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Rh Blood Group
Teratogenicity

